Summary

The pharmaceutical manufacturing equipment market is projected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. The major factors driving the market growth of the pharmaceutical manufacturing equipment market include increasing number of regulatory frameworks established worldwide to support innovation and safety in drugs, growing demand for generics globally, rising healthcare investment, and growing requirement for flexibility in pharmaceutical manufacturing. Emerging markets for pharmaceutical manufacturing, especially in the Middle East and Africa, is also a key factor driving the demand for technologically advanced pharmaceutical manufacturing equipment.
Packaging machines are expected to register the highest CAGR during the forecast period followed by spray drying equipment
Pharmaceutical packaging machines are critical in the drug manufacturing process as they ensure the quality and safety of medications while meeting regulatory requirements. ackaging machines equipped with serialization capabilities enable unique identification and tracking of individual pharmaceutical products, facilitating supply chain transparency and product authentication, thereby driving their demand. There is a growing emphasis on sustainable packaging practices in the pharmaceutical industry. Packaging machines that support eco-friendly packaging materials, such as recyclable or biodegradable materials, are in demand. Using pharmaceutical spray drying equipment helps ensure that the active pharmaceutical ingredient (API) is evenly distributed throughout the drug formulation and that the final product meets the required specifications for quality, purity, and potency. The efficient and precise spray drying of drug formulations is essential to produce high-quality drug products that are safe and effective for patient use, thereby driving their demand.
Liquid end-product type is expected to register the highest CAGR during the forecast period followed by solid end-product type
Liquid end-product type covers different types of liquid dosage forms including solutions, syrups, suspensions, and emulsions, among others. There is a growing demand for syrups. They offer accurate dosage of drug in a concentrated sugar solution, thus masking the unpleasant taste and therefore being preferred, especially by the geriatric population and children. Technological advancements, extensive research and development activities, and innovation in clinical trials have allowed manufacturers to substantially enhance shelf-life of liquid dosage forms, thereby making them a feasible alternative to many solid dosage forms which have less solubility. Liquid medications have higher bioavailability compared to solid dosage forms, meaning that more of the active ingredient is absorbed into the bloodstream. This can lead to a more effective treatment and a reduced risk of side effects, which is another factor driving their demand.
Asia Pacific is expected to register the highest CAGR during forecast period followed by Europe
Industry players in Asia Pacific are working collaboratively with the government to tackle the shortages of drugs. In addition, high-rate of branded drugs and the expiry of key drug patents are also driving the demand for the adoption of generics. The governments and industry players across the region aim to improve pharmaceutical manufacturing facilities by adopting the latest pharmaceutical manufacturing equipment to serve the growing demand for drugs, eliminate drug shortages, and expand production capacities. India has the highest number of US-FDA-compliant pharma plants outside the US. It is home to over 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities and a highly skilled resource pool. Furthermore, the government of India has implemented schemes, including the Production Linked Incentive (PLI) scheme to boost domestic manufacturing capacity, including high-value products across the global supply chain.
Germany was one of the top importers and exporters of pharmaceutical products in FY 2021. The presence of a favorable policy framework, a well-established healthcare system, increasing pharmaceutical R&D expenditure, and rising demand for branded and generic drugs are the major factors driving the potential of the pharmaceutical market in the country. Germany is home to several major pharmaceutical companies, including Bayer, Merck KGaA, Boehringer Ingelheim, etc. Several pharmaceutical companies indicate the presence of several major pharmaceutical manufacturing facilities in the country, boosting the adoption of pharmaceutical manufacturing equipment across the country. The French government implemented several measures to streamline the regulatory process and promote research and development. For instance, in 2023, the government will form a new dedicated committee, which will include representatives of the French pharma industry, health professionals, and patients to lay the foundations for a longer-term approach to preventing and managing supply chain issues.
The break-up of profile of primary participants in the pharmaceutical manufacturing equipment market-
• By Company Type: Tier 1 – 40%, Tier 2 – 35%, Tier 3 – 25%
• By Designation Type: C Level – 48%, Director Level – 33% , Others – 19%
• By Region Type: North America – 35%, Europe – 18%, Asia Pacific – 40%, Rest of the World – 7%

The major players of pharmaceutical manufacturing equipment market are GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US) among others.
Research Coverage
The report segments the pharmaceutical manufacturing equipment market and forecasts its size based on equipment type, end-product type, and region. The report also provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the market growth. The report also covers qualitative aspects in addition to the quantitative aspects of the market.
Reasons to buy the report:
The report will help the market leaders/new entrants in this market with information on the closest approximate revenues for the overall pharmaceutical manufacturing equipment market and related segments. This report will help stakeholders understand the competitive landscape and gain more insights to strengthen their position in the market and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (globally increasing demand for generics, rising need for flexible pharmaceutical manufacturing, and growing implementation of regulatory frameworks and guidelines), restraints (increasing global demand for refurbished pharmaceutical manufacturing equipment), opportunities (adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages, emerging markets and increasing focus on sustainability, and integration of artificial intelligence (AI) with inspection equipment to provide better quality assurance), and challenges (rising costs and expenditures related to usage of pharmaceutical manufacturing equipment) influencing the growth of the pharmaceutical manufacturing equipment market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmaceutical manufacturing equipment market
• Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical manufacturing equipment market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 INCLUSIONS AND EXCLUSIONS 32
TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS 32
1.4 STUDY SCOPE 32
1.4.1 MARKETS COVERED 32
FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SEGMENTATION 32
1.4.2 GEOGRAPHICAL SCOPE 33
FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC SEGMENTATION 33
1.4.3 YEARS CONSIDERED 33
1.5 CURRENCY CONSIDERED 34
1.6 LIMITATIONS 34
1.7 STAKEHOLDERS 34
1.8 RECESSION IMPACT 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN 35
2.1.1 SECONDARY AND PRIMARY RESEARCH 37
2.1.2 SECONDARY DATA 37
2.1.2.1 Major secondary sources 38
2.1.2.2 Key data from secondary sources 38
2.1.3 PRIMARY DATA 38
2.1.3.1 Primary interviews with experts 39
2.1.3.2 Key data from primary sources 39
2.1.3.3 Key industry insights 40
2.1.3.4 Breakdown of primaries 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 41
2.2.1 BOTTOM-UP APPROACH 42
2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side) 42
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 42
2.2.2 TOP-DOWN APPROACH 43
2.2.2.1 Approach to arrive at market size through top-down analysis (supply side) 43
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION 44
2.4 RESEARCH ASSUMPTIONS 45
FIGURE 8 ASSUMPTIONS FOR RESEARCH STUDY 45
2.5 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT 46
2.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 46
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS 46
3 EXECUTIVE SUMMARY 47
FIGURE 9 PACKAGING MACHINES TO HOLD DOMINANT SHARE OF MARKET 48
FIGURE 10 LIQUID END PRODUCT TYPE TO CLAIM LARGEST SHARE IN MARKET 48
FIGURE 11 ASIA PACIFIC HELD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2022 49
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 50
FIGURE 12 RISING DEMAND FOR GENERICS AND GROWING NECESSITY FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO PROVIDE OPPORTUNITIES FOR PLAYERS IN MARKET 50
4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 51
FIGURE 13 PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 51
4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 51
FIGURE 14 LIQUID SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 51
4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY 52
FIGURE 15 US TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 16 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Rising demand for generics 54
5.2.1.2 Need for flexible pharmaceutical manufacturing 54
5.2.1.3 Growing implementation and adoption of regulatory guidelines 54
FIGURE 17 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS 55
5.2.2 RESTRAINTS 56
5.2.2.1 Demand for refurbished equipment 56
FIGURE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages 57
5.2.3.2 Integration of artificial intelligence with inspection equipment to provide better quality assurance 57
5.2.3.3 Emerging markets and increased focus on sustainability 57
FIGURE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES 58
5.2.4 CHALLENGES 58
5.2.4.1 Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment 58
FIGURE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES 59
5.3 VALUE CHAIN ANALYSIS 59
FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 59
5.4 ECOSYSTEM MAPPING 61
FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 61
TABLE 3 COMPANIES AND THEIR ROLE IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM 61
5.5 PRICING ANALYSIS 62
5.5.1 COMPANY-WISE AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE 62
TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE 62
FIGURE 23 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT BY KEY PLAYERS, BY EQUIPMENT TYPE (USD) 63
TABLE 5 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY THREE GLOBAL PLAYERS, BY EQUIPMENT TYPE 63
TABLE 6 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, BY REGION 64
FIGURE 24 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, 2019–2028 64
5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
5.7 TECHNOLOGY ANALYSIS 65
5.7.1 INDUSTRY 4.0 65
5.7.2 COMPUTER VISION 65
5.7.3 RADIO FREQUENCY IDENTIFICATION 66
5.8 PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 26 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.8.1 BARGAINING POWER OF SUPPLIERS 67
5.8.2 BARGAINING POWER OF BUYERS 67
5.8.3 THREAT OF NEW ENTRANTS 67
5.8.4 THREAT OF SUBSTITUTES 67
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 68
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
FIGURE 27 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL INDUSTRY ON BUYING PROCESS 68
TABLE 7 INFLUENCE OF STAKEHOLDERS IN TOP THREE END-USER INDUSTRIES ON BUYING PROCESS 68
5.9.2 BUYING CRITERIA 69
FIGURE 28 KEY BUYING CRITERIA FOR PHARMACEUTICAL INDUSTRY 69
TABLE 8 KEY BUYING CRITERIA OF TOP THREE INDUSTRIES 69
5.10 CASE STUDIES 69
TABLE 9 ALCAMI CORPORATION CHOOSES SYNTEGON TO INCREASE ITS VIAL FILLING FLEXIBILITY 69
TABLE 10 LEADING MANUFACTURER OF GENERIC DRUG PRODUCTS IN RUSSIA CHOOSES GEA GROUP TO EXPAND THEIR REACH AND INTEGRATE ADVANCED MANUFACTURING EQUIPMENT 70
TABLE 11 CDM LAVOISIER ADOPTS SYNTEGON AIM 3000 FOR INSPECTION OF 30 DIFFERENT PRODUCTS ON FOUR PACKAGING FORMATS 70
5.11 TRADE ANALYSIS 71
FIGURE 29 IMPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION) 71
FIGURE 30 EXPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017–2021 (USD MILLION) 72
5.12 PATENT ANALYSIS 73
5.12.1 LIST OF MAJOR PATENTS 74
TABLE 12 KEY PATENTS IN AREA OF PHARMACEUTICAL MANUFACTURING EQUIPMENT 74
5.13 KEY CONFERENCES AND EVENTS, 2022–2023 75
TABLE 13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION-WISE CONFERENCES AND EVENTS 75
5.14 REGULATIONS AND STANDARDS 76
5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 17 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.14.2 STANDARDS 78
TABLE 18 STANDARDS FOLLOWED BY MANUFACTURERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT 78
6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 79
6.1 INTRODUCTION 80
FIGURE 31 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE 80
FIGURE 32 PACKAGING MACHINES TO LEAD MARKET THROUGHOUT FORECAST PERIOD 81
TABLE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 81
TABLE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 82
6.2 PACKAGING MACHINES 82
6.2.1 RISING NECESSITY FOR ENSURING PROTECTION AGAINST DAMAGE AND CONTAMINATION 82
TABLE 21 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 83
TABLE 22 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 83
TABLE 23 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 83
TABLE 24 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 84
TABLE 25 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 84
TABLE 26 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 84
TABLE 27 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 85
TABLE 28 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 85
6.3 FILLING MACHINES 85
6.3.1 GROWING DEMAND FOR ENSURING PRECISION FILLING OF DRUG FORMULATIONS 85
TABLE 29 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 86
TABLE 30 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 86
TABLE 31 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 87
TABLE 32 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 87
TABLE 33 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 87
TABLE 34 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 88
TABLE 35 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 88
TABLE 36 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 88
6.4 SPRAY DRYING EQUIPMENT 89
6.4.1 GROWING NECESSITY FOR HIGH-QUALITY DRUGS 89
TABLE 37 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 89
TABLE 38 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 90
TABLE 39 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 90
TABLE 40 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 90
TABLE 41 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 91
TABLE 42 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 91
TABLE 43 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 91
TABLE 44 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 92
6.5 MIXING AND BLENDING MACHINES 92
6.5.1 DEMAND TO MAINTAIN UNIFORMITY OF DRUG FORMULATIONS FOR HOMOGENEITY TO DRIVE MARKET 92
TABLE 45 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 93
TABLE 46 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 93
TABLE 47 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 93
TABLE 48 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 94
TABLE 49 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 94
TABLE 50 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 94
TABLE 51 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 95
TABLE 52 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 95
6.6 MILLING EQUIPMENT 95
6.6.1 RISING NECESSITY TO IMPROVE SOLUBILITY OF DRUGS 95
TABLE 53 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 96
TABLE 54 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 96
TABLE 55 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 96
TABLE 56 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 97
TABLE 57 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 97
TABLE 58 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 97
TABLE 59 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 98
TABLE 60 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 98
6.7 EXTRUSION EQUIPMENT 98
6.7.1 NECESSITY FOR DEVELOPING DRUGS IN EFFECTIVE SHAPES AND MAINTAINING PROPER DRUG FORMULATION 98
TABLE 61 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 99
TABLE 62 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 99
TABLE 63 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 100
TABLE 64 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 100
TABLE 65 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 100
TABLE 66 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 101
TABLE 67 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 101
TABLE 68 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 101
6.8 TABLET COMPRESSION PRESSES 102
6.8.1 RISING DEMAND TO PRODUCE LARGE BATCHES OF TABLETS QUICKLY 102
TABLE 69 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 102
TABLE 70 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 103
TABLE 71 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 103
TABLE 72 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 103
TABLE 73 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 104
TABLE 74 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 104
TABLE 75 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 104
TABLE 76 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 105
6.9 INSPECTION EQUIPMENT 105
6.9.1 RISING DEMAND TO ADHERE TO QUALITY STANDARDS 105
TABLE 77 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 106
TABLE 78 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 106
TABLE 79 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019–2022 (USD MILLION) 106
TABLE 80 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023–2028 (USD MILLION) 107
TABLE 81 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019–2022 (USD MILLION) 107
TABLE 82 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023–2028 (USD MILLION) 107
TABLE 83 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019–2022 (USD MILLION) 108
TABLE 84 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023–2028 (USD MILLION) 108
7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE 109
7.1 INTRODUCTION 110
FIGURE 33 LIQUID END-PRODUCT TYPE TO HOLD LARGER MARKET SHARE THROUGHOUT FORECAST PERIOD 110
TABLE 85 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2019–2022 (USD MILLION) 110
TABLE 86 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2023–2028 (USD MILLION) 111
7.2 SOLID 111
7.2.1 RISING DEMAND FOR TABLETS 111
7.3 LIQUID 112
7.3.1 EASE OF ADMINISTRATION AND HIGH SOLUBILITY 112
8 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION 113
8.1 INTRODUCTION 114
FIGURE 34 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 114
FIGURE 35 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 115
TABLE 87 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 115
TABLE 88 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 115
8.2 NORTH AMERICA 116
FIGURE 36 NORTH AMERICA: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 117
FIGURE 37 US TO REGISTER HIGHEST CAGR IN NORTH AMERICAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 118
TABLE 89 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION) 118
TABLE 90 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 118
TABLE 91 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 119
TABLE 92 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 119
TABLE 93 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 120
TABLE 94 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 120
TABLE 95 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 121
TABLE 96 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 121
TABLE 97 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 122
TABLE 98 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 122
8.2.1 US 123
8.2.1.1 Stringent regulatory framework and growing demand for innovative drugs 123
8.2.2 CANADA 123
8.2.2.1 Establishment of new drug development facilities and government measures 123
8.2.3 MEXICO 124
8.2.3.1 Development of pharmaceutical manufacturing units by global players 124
8.3 EUROPE 124
FIGURE 38 EUROPE: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 125
FIGURE 39 GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 126
TABLE 99 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION) 126
TABLE 100 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 126
TABLE 101 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 127
TABLE 102 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 127
TABLE 103 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 128
TABLE 104 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 128
TABLE 105 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 129
TABLE 106 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 129
TABLE 107 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 130
TABLE 108 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 130
TABLE 109 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 131
TABLE 110 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 131
8.3.1 UK 132
8.3.1.1 Strong pharmaceutical manufacturing sector 132
8.3.2 GERMANY 132
8.3.2.1 Presence of major pharmaceutical players 132
8.3.3 FRANCE 132
8.3.3.1 Growing demand for generics 132
8.3.4 ITALY 133
8.3.4.1 Growing government support 133
8.3.5 REST OF EUROPE 133
8.4 ASIA PACIFIC 134
FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT 135
FIGURE 41 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD 136
TABLE 111 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019–2022 (USD MILLION) 136
TABLE 112 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 136
TABLE 113 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 137
TABLE 114 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 137
TABLE 115 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 138
TABLE 116 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 138
TABLE 117 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 139
TABLE 118 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 139
TABLE 119 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 140
TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 140
TABLE 121 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 141
TABLE 122 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 141
8.4.1 CHINA 142
8.4.1.1 Growing contract pharmaceutical manufacturing 142
8.4.2 JAPAN 142
8.4.2.1 Collaboration of associations and industry players to eliminate drug shortages 142
8.4.3 INDIA 143
8.4.3.1 Establishment of new pharmaceutical manufacturing units 143
8.4.4 SOUTH KOREA 143
8.4.4.1 Increasing government initiatives to support market growth 143
8.4.5 REST OF ASIA PACIFIC 143
8.5 REST OF THE WORLD 144
FIGURE 42 SOUTH AMERICA TO DOMINATE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW DURING FORECAST PERIOD 144
TABLE 123 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 144
TABLE 124 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2023–2028 (USD MILLION) 145
TABLE 125 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019–2022 (USD MILLION) 145
TABLE 126 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023–2028 (USD MILLION) 145
8.5.1 MIDDLE EAST & AFRICA 146
8.5.1.1 Growing regulatory environment 146
8.5.2 SOUTH AMERICA 146
8.5.2.1 Growing pharmaceutical manufacturing infrastructure 146
9 COMPETITIVE LANDSCAPE 147
9.1 OVERVIEW 147
TABLE 127 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET 147
9.2 REVENUE ANALYSIS OF TOP FIVE PLAYERS 149
FIGURE 43 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS (2022) 149
9.3 MARKET SHARE ANALYSIS, 2022 149
TABLE 128 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE OF KEY COMPANIES 150
FIGURE 44 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS 150
9.4 COMPANY EVALUATION QUADRANT 152
9.4.1 STARS 152
9.4.2 EMERGING LEADERS 152
9.4.3 PERVASIVE PLAYERS 152
9.4.4 PARTICIPANTS 152
FIGURE 45 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY EVALUATION QUADRANT, 2022 153
9.5 SMALL- AND MEDIUM-SIZED ENTERPRISES EVALUATION QUADRANT, 2022 154
9.5.1 PROGRESSIVE COMPANIES 154
9.5.2 RESPONSIVE COMPANIES 154
9.5.3 DYNAMIC COMPANIES 154
9.5.4 STARTING BLOCKS 154
FIGURE 46 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (GLOBAL): SME EVALUATION QUADRANT, 2022 155
9.6 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY FOOTPRINT 156
TABLE 129 COMPANY FOOTPRINT 156
TABLE 130 PRIMARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT 157
TABLE 131 SECONDARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT 158
TABLE 132 TYPE: COMPANY FOOTPRINT 159
TABLE 133 REGION: COMPANY FOOTPRINT 161
9.7 COMPETITIVE BENCHMARKING 162
TABLE 134 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 162
TABLE 135 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 163
9.8 COMPETITIVE SITUATIONS AND TRENDS 165
9.8.1 PRODUCT LAUNCHES 165
TABLE 136 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, APRIL 2020–JANUARY 2023 165
9.8.2 DEALS 166
TABLE 137 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2021–MARCH 2023 166
10 COMPANY PROFILES 169
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
10.1 KEY PLAYERS 169
10.1.1 GEA GROUP AKTIENGESELLSCHAFT 169
TABLE 138 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 169
FIGURE 47 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 170
TABLE 139 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 170
TABLE 140 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES & DEVELOPMENTS 171
TABLE 141 GEA GROUP AKTIENGESELLSCHAFT: DEALS 172
10.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A 173
TABLE 142 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A : COMPANY OVERVIEW 173
TABLE 143 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A: PRODUCT/SOLUTIONS/SERVICES OFFERED 173
10.1.3 SYNTEGON TECHNOLOGY GMBH 176
TABLE 144 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 176
TABLE 145 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 177
TABLE 146 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES 178
TABLE 147 SYNTEGON TECHNOLOGY GMBH: DEALS 178
10.1.4 ACG 180
TABLE 148 ACG: COMPANY OVERVIEW 180
TABLE 149 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 180
10.1.5 THERMO FISHER SCIENTIFIC INC. 183
TABLE 150 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 183
FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 184
TABLE 151 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 184
TABLE 152 THERMO FISHER SCIENTIFIC INC.: DEALS 185
10.1.6 ROMACO GROUP 187
TABLE 153 ROMACO GROUP: COMPANY OVERVIEW 187
TABLE 154 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 187
TABLE 155 ROMACO GROUP: PRODUCT LAUNCHES 188
TABLE 156 ROMACO GROUP: DEALS 189
10.1.7 KÖRBER AG 190
TABLE 157 KÖRBER AG: COMPANY OVERVIEW 190
FIGURE 49 KÖRBER AG: COMPANY SNAPSHOT 191
TABLE 158 KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 191
TABLE 159 KÖRBER AG: DEALS 192
10.1.8 MARCHESINI GROUP 193
TABLE 160 MARCHESINI GROUP: COMPANY OVERVIEW 193
TABLE 161 MARCHESINI GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 193
TABLE 162 MARCHESINI GROUP: PRODUCT LAUNCHES 194
TABLE 163 MARCHESINI GROUP: DEALS 195
10.1.9 MG2 S.R.L 196
TABLE 164 MG2 S.R.L.: COMPANY OVERVIEW 196
TABLE 165 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196
TABLE 166 MG2 S.R.L.: PRODUCT LAUNCHES 197
10.1.10 GLATT GMBH 198
TABLE 167 GLATT GMBH: COMPANY OVERVIEW 198
TABLE 168 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 199
10.2 OTHER PLAYERS 200
10.2.1 BAKER PERKINS 200
TABLE 169 BAKER PERKINS: COMPANY OVERVIEW 200
10.2.2 BAUSCH+STRÖBEL 201
TABLE 170 BAUSCH+ STRÖBEL: COMPANY OVERVIEW 201
10.2.3 COPERION 202
TABLE 171 COPERION: COMPANY OVERVIEW 202
10.2.4 ELIZABETH COMPANIES 203
TABLE 172 ELIZABETH COMPANIES: COMPANY OVERVIEW 203
10.2.5 FETTE COMPACTING 203
TABLE 173 FETTE COMPACTING: COMPANY OVERVIEW 203
10.2.6 FREUND-VECTOR 204
TABLE 174 FREUND-VECTOR: COMPANY OVERVIEW 204
10.2.7 KORSCH 205
TABLE 175 KORSCH: COMPANY OVERVIEW 205
10.2.8 L.B. BOHLE 206
TABLE 176 L.B. BOHLE: COMPANY OVERVIEW 206
10.2.9 LFA MACHINES 206
TABLE 177 LFA MACHINES: COMPANY OVERVIEW 206
10.2.10 CVC TECHNOLOGIES, INC. 207
TABLE 178 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW 207
10.2.11 OHARA TECHNOLOGIES 207
TABLE 179 OHARA TECHNOLOGIES: COMPANY OVERVIEW 207
10.2.12 PRISM PHARMA MACHINERY 208
TABLE 180 PRISM PHARMA MACHINERY: COMPANY OVERVIEW 208
10.2.13 SAINTYCO 209
TABLE 181 SAINTYCO: COMPANY OVERVIEW 209
10.2.14 SILVERSON 209
TABLE 182 SILVERSON: COMPANY OVERVIEW 209
10.2.15 YENCHEN MACHINERY 210
TABLE 183 YENCHEN MACHINERY: COMPANY OVERVIEW 210
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
11 ADJACENT AND RELATED MARKETS 211
11.1 INTRODUCTION 211
11.2 LIMITATIONS 211
11.3 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT 212
11.3.1 INTRODUCTION 212
TABLE 184 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2019–2022 (USD MILLION) 212
TABLE 185 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2023–2028 (USD MILLION) 212
11.4 IDM FIRMS 213
11.4.1 FOCUS ON SEMICONDUCTOR DESIGN AND PRODUCTION AND HAVE INTERNAL CAPABILITY TO PERFORM BOTH 213
TABLE 186 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 213
TABLE 187 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 214
11.5 OSAT COMPANIES 214
11.5.1 LESS INVESTMENTS AND ATTRACTIVE REVENUE FOSTER GROWTH OF OSAT COMPANIES 214
TABLE 188 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 215
TABLE 189 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 215
11.6 FOUNDRIES 215
11.6.1 INCREASED SEMICONDUCTOR OUTSOURCING BY FABLESS COMPANIES 215
TABLE 190 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019–2022 (USD MILLION) 216
TABLE 191 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023–2028 (USD MILLION) 216
12 APPENDIX 217
12.1 INSIGHTS FROM INDUSTRY EXPERTS 217
12.2 DISCUSSION GUIDE 218
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221
12.4 CUSTOMIZATION OPTIONS 223
12.5 RELATED REPORTS 223
12.6 AUTHOR DETAILS 224